Yes, NADP+ and its reduced form, NADPH, are involved in cancer drug resistance. Several chemotherapy agents work by increasing oxidative stress within cancer cells. By generating NADPH, cancer cells can effectively counteract this stress, thereby reducing the efficacy of these drugs. Moreover, NADPH is involved in the function of various detoxifying enzymes that can metabolize and inactivate chemotherapeutic agents, contributing to drug resistance.
